CD38 expression in patients with B-CLL
| Characteristic . | CD38− (56%) . | CD38+(44%) . | P . |
|---|---|---|---|
| Rai | .17 | ||
| 0-II | 72% | 74.4% | |
| III-IV | 28% | 26.6% | |
| Binet | .10 | ||
| A + B | 79% | 71% | |
| C | 20% | 29% | |
| Lymph nodes | .004 | ||
| 0 | 40% | 16% | |
| 1-2 | 31% | 44% | |
| 3 (or more) | 29% | 40% | |
| Palpable liver | .05 | ||
| Yes | 9% | 18% | |
| No | 91% | 82% | |
| Palpable spleen | .26 | ||
| Yes | 28% | 33% | |
| No | 72% | 67% | |
| Hemoglobin g/dL | 13 (4-17) | 12.2 (7.2-17.3) | .001 |
| Platelets × 103/μL | 163 (27-541) | 145 (12-403) | .14 |
| WBC × 103/μL | 60 (12-652) | 64.7 (3-438.5) | .45 |
| β2M mg/L | 2 (1.3-6.9) | 3.4 (1.6-15.4) | .00001 |
| Lymphocytosis × 103/μL | 83 (12.3-265.7) | 75 (6.3-340.1) | .25 |
| Age (y) | 60 (33-82) | 62 (29-83) | .56 |
| Sex | .26 | ||
| Male | 58% | 65% | |
| Female | 42% | 35% |
| Characteristic . | CD38− (56%) . | CD38+(44%) . | P . |
|---|---|---|---|
| Rai | .17 | ||
| 0-II | 72% | 74.4% | |
| III-IV | 28% | 26.6% | |
| Binet | .10 | ||
| A + B | 79% | 71% | |
| C | 20% | 29% | |
| Lymph nodes | .004 | ||
| 0 | 40% | 16% | |
| 1-2 | 31% | 44% | |
| 3 (or more) | 29% | 40% | |
| Palpable liver | .05 | ||
| Yes | 9% | 18% | |
| No | 91% | 82% | |
| Palpable spleen | .26 | ||
| Yes | 28% | 33% | |
| No | 72% | 67% | |
| Hemoglobin g/dL | 13 (4-17) | 12.2 (7.2-17.3) | .001 |
| Platelets × 103/μL | 163 (27-541) | 145 (12-403) | .14 |
| WBC × 103/μL | 60 (12-652) | 64.7 (3-438.5) | .45 |
| β2M mg/L | 2 (1.3-6.9) | 3.4 (1.6-15.4) | .00001 |
| Lymphocytosis × 103/μL | 83 (12.3-265.7) | 75 (6.3-340.1) | .25 |
| Age (y) | 60 (33-82) | 62 (29-83) | .56 |
| Sex | .26 | ||
| Male | 58% | 65% | |
| Female | 42% | 35% |